News and Media
OICR introduces groundbreaking test proven to find traces of cancer in blood
The highly sensitive Plasma Whole Genome Sequencing assay is available for clinical research studies for any tumour type through OICR’s accredited genomics lab. A new blood test proven to detect residual signs of cancer could revolutionize how treatments are monitored and assessed, and it’s now available to research studies through the Ontario Institute for Cancer […]
Read the story
Sep 27, 2023
Wave of medical imaging innovation hits shores of Lake Superior
Sep 19, 2023
Ask a Cancer Researcher: How does blood change as we age?
Sep 14, 2023
New OICR investigator combines physics, chemistry, and artificial intelligence to improve tissue imaging
Aug 31, 2023
New member of executive team will strengthen OICR’s commitment to patients, equity and impact
Aug 29, 2023
The Next Generation: Jingping Qiao
Aug 29, 2023
Ask a Cancer Researcher: How can we predict if breast cancer will come back?
OICR Brand Guidelines
Jul 28, 2021
Download the OICR brand guidelines.
Jun 14, 2023
Cancer researchers focused on bringing new discoveries to patients get two-year funding awards
May 04, 2023
Investment in Ontario drug discovery research will help develop new cancer medicines for patients
Apr 04, 2023
Third major accreditation to help OICR Genomics power next generation of precision medicine
@OICR_News on Twitter
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.